The other triple-negative breast cancer: Immunohistochemical and clinicopathologic characterization of the Claudin-low subtype.

Abstract

1129 Background: The triple-negative (TN) immunohistochemical (IHC) definition for basal-like breast cancer lacks specificity. This aggressive subtype is best identified with the addition of EGFR and CK5/6 biomarkers; however, the subgroup of TN breast cancers that lack expression of these biomarkers (5NP) is mostly uncharacterized. Recently, an additional… (More)

Topics

Cite this paper

@article{Voduc2011TheOT, title={The other triple-negative breast cancer: Immunohistochemical and clinicopathologic characterization of the Claudin-low subtype.}, author={David K. Voduc and Maggie Chon U. Cheang and Andrea Prat and X. He and Scott Tyldesley and Jerry A. Snider and Katherine Deschryver and S. Davies and Michael J Ellis and Charles M. Perou and Torben Nielsen}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2011}, volume={29 15_suppl}, pages={1129} }